SPRB

Spruce Biosciences Inc. (SPRB)

Market Closed
15 Dec, 20:00
NASDAQ NASDAQ
$
80. 70
-2.7
-3.24%
$
60.69M Market Cap
- P/E Ratio
0% Div Yield
27,552 Volume
-1.12 Eps
$ 83.4
Previous Close
Day Range
79.27 83.05
Year Range
7 2,542.5
Want to track SPRB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Shareholders Are Invited By The Schall Law Firm To Join An Investigation Into Whether Spruce Biosciences Inc Breached Securities Laws

Shareholders Are Invited By The Schall Law Firm To Join An Investigation Into Whether Spruce Biosciences Inc Breached Securities Laws

LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Spruce Biosciences, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - SPRB

Spruce Biosciences, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - SPRB

NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.

Accesswire | 1 year ago
Spruce Biosciences Inc Might Have Committed Securities Law Violations And The Schall Law Firm Seeks Investors To Help

Spruce Biosciences Inc Might Have Committed Securities Law Violations And The Schall Law Firm Seeks Investors To Help

LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
SPRB ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Spruce Biosciences, Inc.

SPRB ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Spruce Biosciences, Inc.

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.

Accesswire | 1 year ago
Shareholders In Spruce Biosciences Inc Are Encouraged To Contact The Schall Law Firm About Possible Securities Fraud

Shareholders In Spruce Biosciences Inc Are Encouraged To Contact The Schall Law Firm About Possible Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Did Spruce Biosciences, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - SPRB

Did Spruce Biosciences, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - SPRB

NEW YORK, NY / ACCESSWIRE / August 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.

Accesswire | 1 year ago
The Schall Law Firm Is Investigating Spruce Biosciences Inc For Potential Securities Law Violations And Investors Are Urged To Reach Out

The Schall Law Firm Is Investigating Spruce Biosciences Inc For Potential Securities Law Violations And Investors Are Urged To Reach Out

LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
SPRB STOCK ALERT: Levi & Korsinsky Notifies Spruce Biosciences, Inc. Investors of an Ongoing Investigation

SPRB STOCK ALERT: Levi & Korsinsky Notifies Spruce Biosciences, Inc. Investors of an Ongoing Investigation

NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.

Accesswire | 1 year ago
An Securities Fraud Inquiry Has Been Opened Into Spruce Biosciences Inc And The Schall Law Firm Seeks Shareholder Participation

An Securities Fraud Inquiry Has Been Opened Into Spruce Biosciences Inc And The Schall Law Firm Seeks Shareholder Participation

LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Spruce Biosciences, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Spruce Biosciences (SPRB)

Spruce Biosciences, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Spruce Biosciences (SPRB)

NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.

Accesswire | 1 year ago
Investors In Spruce Biosciences Inc Are Urged To Join The Schall Law Firm In An Investigation For Possible Securities Law Violations

Investors In Spruce Biosciences Inc Are Urged To Join The Schall Law Firm In An Investigation For Possible Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Spruce Biosciences, Inc. ("Spruce" or "the Company") (NASDAQ:SPRB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Lost Money on Spruce Biosciences, Inc. (SPRB)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

Lost Money on Spruce Biosciences, Inc. (SPRB)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Spruce Biosciences, Inc. ("Spruce Biosciences") (NASDAQ:SPRB) concerning possible violations of federal securities laws. Spruce is the subject of a Seeking Alpha report published on March 13, 2024.

Accesswire | 1 year ago
Loading...
Load More